<DOC>
	<DOCNO>NCT01515878</DOCNO>
	<brief_summary>It hypothesize consistent use Hemocontrol TM biofeedback function improve long-term cardiovascular outcome , mediate reduced hypertension due fluid overload reduce incidence intradialytic hypotensive episode</brief_summary>
	<brief_title>Hemocontrol 's Effectiveness Reduction Cardiovascular Long-term EventS</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>1 . Age 65 year old 2 . Arterial Hypertension : predialysis SBP &gt; 140 mmHg and/or DBP &gt; 90 mmHg least 50 % previous month dialysis session receive least one antihypertensive pharmacological drug include diuretic , disregard blood pressure value 3 . On three time per week hemodialysis schedule 4 . Time hemodialysis le 6 month 5 . Able measure blood pressure home ( aid care giver ) 6 . Signed informed consent 1 . Active neoplastic disease 2 . Mental illness 3 . Pregnancy 4 . Single needle treatment 5 . Inability , judge investigator , follow understand protocol instruction 6 . Blood flow rate le 200 mL/min 7 . Patients time recruitment need clinical indication special renal replacement therapy and/or treatment one follow modality : HDF similar diffusiveconvective therapy , treatment time &gt; 5h , blood temperature control , isolate UF profile Na/UFR 8 . Patients life expectancy short 6 month 9 . Patients list transplant within next 6 month 10 . Predialysis Hemoglobin level great 13.5 g/dl 11 . History major cardiovascular event run period</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>